The U.S. Supreme Court has rejected an appeal by German company Bayer AG to dismiss legal claims by customers who assert one of its products — glyphosate-based Roundup weedkiller — causes cancer.
In 2015, Hardeman was diagnosed with non-Hodgkin’s lymphoma and contended that Bayer hadn’t given a warning as to the cancer risks of glyphosate, The Washington Post reported.
Bayer acquired Monsanto, the original maker of Roundup, in 2018.
Bayer is currently in the midst of thousands of lawsuits, with another Bayer appeal on the horizon for the Supreme Court in the weeks to come, Reuters reported.
The Court’s rejection of the current appeal by Bayer led to a 2.9 percent dip in the company’s shares.
In its annual report released in March, Bayer said that about 107,000 of its approximately 138,000 cases had been resolved.
Bayer has asked for a review of the Supreme Court’s decision in the Hardeman case. »
